Technical Analysis for EVOK - Evoke Pharma, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.46 | 5.05% | 0.02 |
EVOK closed up 5.05 percent on Friday, April 26, 2024, on 23 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 5.05% | |
| 180 Bearish Setup | Bearish Swing Setup | 5.05% | |
| NR7 | Range Contraction | 5.05% | |
| NR7-2 | Range Contraction | 5.05% | |
| Narrow Range Bar | Range Contraction | 5.05% | |
| Inside Day | Range Contraction | 5.05% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 9 hours ago |
| 10 DMA Resistance | about 10 hours ago |
| Rose Above Previous Day's High | about 14 hours ago |
| Rose Above 10 DMA | about 14 hours ago |
| Up 5% | about 14 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Evoke Pharma, Inc., a specialty pharmaceutical company, engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded in 2007 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Disease Diabetes Gastrointestinal Gastroenterology Diabetes Mellitus Chloroarenes Antiemetics Benzamides Nasal Spray Gastrointestinal Disorders Gastroparesis Metoclopramide Prolactin Releasers
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Disease Diabetes Gastrointestinal Gastroenterology Diabetes Mellitus Chloroarenes Antiemetics Benzamides Nasal Spray Gastrointestinal Disorders Gastroparesis Metoclopramide Prolactin Releasers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.39 |
| 52 Week Low | 0.4159 |
| Average Volume | 37,922 |
| 200-Day Moving Average | 1.03 |
| 50-Day Moving Average | 0.59 |
| 20-Day Moving Average | 0.52 |
| 10-Day Moving Average | 0.47 |
| Average True Range | 0.06 |
| RSI (14) | 37.89 |
| ADX | 13.72 |
| +DI | 19.01 |
| -DI | 17.18 |
| Chandelier Exit (Long, 3 ATRs) | 0.49 |
| Chandelier Exit (Short, 3 ATRs) | 0.60 |
| Upper Bollinger Bands | 0.64 |
| Lower Bollinger Band | 0.40 |
| Percent B (%b) | 0.25 |
| BandWidth | 47.52 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0038 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.52 | ||||
| Resistance 3 (R3) | 0.52 | 0.50 | 0.51 | ||
| Resistance 2 (R2) | 0.50 | 0.48 | 0.50 | 0.51 | |
| Resistance 1 (R1) | 0.48 | 0.47 | 0.47 | 0.48 | 0.50 |
| Pivot Point | 0.46 | 0.46 | 0.45 | 0.46 | 0.46 |
| Support 1 (S1) | 0.44 | 0.44 | 0.43 | 0.44 | 0.41 |
| Support 2 (S2) | 0.42 | 0.43 | 0.42 | 0.41 | |
| Support 3 (S3) | 0.39 | 0.42 | 0.40 | ||
| Support 4 (S4) | 0.39 |
